Home › Companies › Filamon LTD

Filamon LTD

Quick facts

Phase 1 pipeline

A novel hGIIA-Vimentin Inhibitor · Oncology
Inhibits hGIIA-Vimentin interaction
Dose expansion

Data from Drug Landscape. Machine-readable: markdown · JSON. Sources: SEC filings, FDA, ClinicalTrials.gov, press releases.